1835667-63-4
1835667-63-4 structure
- Name: Befotertinib
- Chemical Name: Befotertinib
- CAS Number: 1835667-63-4
- Molecular Formula: C29H32F3N7O2
- Molecular Weight: 567.61
- Catalog: Signaling Pathways JAK/STAT Signaling EGFR
- Create Date: 2022-01-15 00:26:52
- Modify Date: 2024-01-04 18:24:28
-
Befotertinib (D-0316) is the third-generation EGFR tyrosine kinase inhibitor. Befotertinib can be used for the research of EGFR T790M-positive non-small cell lung cancer (NSCLC)[1].
| Name | Befotertinib |
|---|
| Description | Befotertinib (D-0316) is the third-generation EGFR tyrosine kinase inhibitor. Befotertinib can be used for the research of EGFR T790M-positive non-small cell lung cancer (NSCLC)[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFR tyrosine kinase[1] |
| References |
| Molecular Formula | C29H32F3N7O2 |
|---|---|
| Molecular Weight | 567.61 |